913634-46-5

Usage

Chemical class

Urea derivatives

Appearance

White crystalline solid

Molecular weight

308.78 g/mol

Pharmaceutical use

Research and development

Pharmacological properties

Anti-inflammatory, analgesic, and anti-tumor activities

Potential medical applications

Treatment of various medical conditions

Additional use

Reagent in chemical synthesis and organic chemistry experiments

Upstream product

• 206273-87-2 4-benzylamino-piperidine-1-carboxylic acid tert-butyl ester 
• 87120-72-7 1-(tert-butoxycarbonyl)-4-aminopiperidine 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 913634-45-4 tert-butyl-4-{[[(4-fluorophenyl)-amino]-carbonyl]amino}-piperidine-1-carboxylate 

Downstream Products

• 913634-47-6 ((S)-1-{4-[3-(4-fluoro-phenyl)-ureido]-piperidine-1-carbonyl}-2,2-dimethyl-propyl)-carbamic acid tert-butyl ester 
• 1020266-18-5 1-(4-fluoro-phenyl)-3-[1-(3-trifluoromethyl-benzenesulfonyl)-piperidin-4-yl]-urea 
• 913634-48-7 1-[1-((S)-2-amino-3,3-dimethyl-buryryl)-piperidin-4-yl]-3-(4-fluoro-phenyl)-urea hydrochloride 

Relevant academic research and scientific papers

Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof

The present invention relates to the novel antibacterial compounds having potent antibacterial activity as inhibitors of peptide deformylase. This invention further relates to pharmaceutically acceptable salts thereof, to processes for their preparation, and to pharmaceutical compositions containing them as an active ingredient.

A NOVEL HYDROXAMIC ACID DERIVATIVE AS PEPTIDE DEFORMYLASE INHIBITOR AND MANUFACTURING METHOD THEREOF

The present invention relates to the novel antibacterial compounds having potent antibacterial activity as inhibitors of peptide deformylase. This invention further relates to pharmaceutically acceptable salts thereof, to processes for their preparation, and to pharmaceutical compositions containing them as an active ingredient.